在肺炎疾病中,长非编码RNA和微RNA之间的相互作用
Jiaqi Li1, Shengyu Huang1, Liangliang Shi1
1Medical Center of Burn Plastic and Wound Repair, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Immunity, inflammation and disease
|January 25, 2024
概括
非编码RNAs (ncRNAs),包括长非编码RNAs (lncRNAs) 和microRNAs (miRNAs),是肺炎疾病的关键调节者. 它们的相互作用提供了有希望的治疗点,尽管药物开发的挑战仍然存在.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
背景情况:
- 非编码RNAs (ncRNAs) 在没有蛋白质合成的情况下调节基因表达.
- 长非编码RNAs (lncRNAs) 和microRNAs (miRNAs) 在免疫反应和细胞过程中至关重要.
- ncRNA相互作用显著影响肺炎疾病.
研究的目的:
- 审查ncRNAs,特别是lncRNA-miRNA相互作用在肺部疾病中的作用.
- 探索涉及ncRNAs的疾病机制和潜在的治疗策略.
- 提供有关急性和慢性肺炎疾病和肺癌的见解.
主要方法:
- 对最近的研究进行了全面的文献综述.
- 在电子数据库中进行搜索:PubMed,科学网,Scopus.
- 专注于IncRNA和miRNA在肺炎疾病中的作用.
主要成果:
- 详细解释miRNA和lncRNA的特征和功能.
- 关于lncRNAs和miRNAs之间潜在的相互作用机制的概述.
- 关于肺炎中lncRNA-miRNA相互作用的最近发现的概述.
结论:
- lncRNAs和miRNAs参与肺炎疾病的所有阶段.
- 基于ncRNA的疗法显示出希望,但在临床应用中面临挑战.
- 开发稳定和有效的ncRNA药物是一个正在进行的研究领域.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
Types of RNA
5.8K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.8K


